# High Potency Statins and the Risk of Diabetes

> **NCT02518503** · — · COMPLETED · sponsor: **Canadian Network for Observational Drug Effect Studies, CNODES** · enrollment: 136966 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Cardiovascular Disease

## Interventions

- **DRUG:** Rosuvastatin (≥10 mg)
- **DRUG:** Atorvastatin (≥20 mg)
- **DRUG:** Simvastatin (≥40 mg)
- **DRUG:** Fluvastatin
- **DRUG:** Pravastatin
- **DRUG:** Lovastatin
- **DRUG:** Rosuvastatin (<10mg)
- **DRUG:** Atorvastatin (<20mg)
- **DRUG:** Simvastatin (<40 mg)

## Key facts

- **NCT ID:** NCT02518503
- **Lead sponsor:** Canadian Network for Observational Drug Effect Studies, CNODES
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 136966 (ACTUAL)
- **Last updated:** 2016-03-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02518503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02518503, "High Potency Statins and the Risk of Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02518503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*